6-Hydroxydopamine increases the level of TNFalpha and bax mRNA in the striatum and induces apoptosis of dopaminergic neurons in hemiparkinsonian rats

Brain Res. 2004 Jan 23;996(2):237-45. doi: 10.1016/j.brainres.2003.10.035.

Abstract

This study was focused on the apoptosis (programmed cell death) induction involved in the loss of dopaminergic (DA-ergic) neurons in 6-hydroxydopamine (6-OHDA) hemiparkinsonian rats. The apoptosis in the striatum and substantia nigra pars compacta (SNpc), was examined 6, 24 h and 7 days after the 6-OHDA lesions employing the TUNEL method. The changes in mRNA levels of pro-apoptotic protein tumor necrosis factor alpha (TNFalpha) and its "death receptor" TNFalphaRI and then bax mRNA, as an important regulator of apoptotic neurodegeneration were followed by RT-PCR procedure. In situ analysis revealed an increased number of TUNEL-positive neurons in 6-OHDA-treated animals in all examined time points. The highest number of apoptotic neurons was detected 24 h after the lesion, both in the ipsilateral striatum (3.41+/-0.18) and SNpc (5.8+/-0.79). A significant increase in the level of TNFalpha mRNA was observed in 6-OHDA-lesioned striatum, with maximal value after 24 h (46%) comparing to the control. In contrast, 6-OHDA did not significantly change the level of TNFalphaRI mRNA in any time point. Six and 24 h post-operatively, we observed a significant increase of bax mRNA expression (40% and 45%, respectively) in the ipsilateral striatum of treated animals in comparison with the right striatum of the controls. However, the highest level of the bax mRNA expression was reached 7 days after the surgery (94%) in the ipsilateral striatum of 6-OHDA-treated animals. These results suggest that striatal injection of 6-OHDA can induce early changes that would be an important regulator of apoptotic neurodegeneration of dopamine-producing neurons, during the first post-operative week.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic Agents / pharmacology*
  • Animals
  • Apoptosis / physiology*
  • Corpus Striatum / drug effects*
  • Corpus Striatum / pathology
  • Dopamine / metabolism
  • Functional Laterality
  • Immunohistochemistry
  • In Situ Nick-End Labeling
  • Male
  • Nerve Degeneration / metabolism
  • Nerve Degeneration / pathology
  • Neurons / drug effects
  • Neurons / pathology
  • Neurons / physiology
  • Oxidopamine / pharmacology*
  • Parkinsonian Disorders / pathology*
  • Proto-Oncogene Proteins / drug effects
  • Proto-Oncogene Proteins c-bcl-2*
  • RNA, Messenger / analysis
  • RNA, Messenger / drug effects
  • Rats
  • Receptors, Tumor Necrosis Factor / drug effects
  • Receptors, Tumor Necrosis Factor / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction
  • Time Factors
  • Tumor Necrosis Factor-alpha / drug effects
  • Tyrosine 3-Monooxygenase / metabolism
  • bcl-2-Associated X Protein

Substances

  • Adrenergic Agents
  • Bax protein, rat
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-bcl-2
  • RNA, Messenger
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • bcl-2-Associated X Protein
  • Oxidopamine
  • Tyrosine 3-Monooxygenase
  • Dopamine